Experimental models of atopic dermatitis and rosacea have shown that both overactivation and deficiency of STAT3 can aggravate barrier dysfunction and inflammation, underscoring STAT3-centered pathways as a critical mechanistic axis [33]. This evidence concerns the gene STAT3 and atopic eczema.